Stroke Risk Assessment in Atrial Fibrillation via Phase-Field Modeling of Thrombus Biomechanics

POSTER

Abstract

Atrial Fibrillation (AF), the most common arrhythmia, is linked to one-third of all thromboembolic strokes. AF-related strokes are typically ischemic and cardioembolic, often fatal or leading to disability, with a high risk of recurrence. Despite the well-established correlation between AF and stroke, its underlying mechanisms remain poorly understood. Structural changes and eventual instabilities in a clot can give rise to microthrombi, potentially releasing emboli and significantly impacting stroke risk. To address this, we introduce a computational pipeline that investigates clotting biomechanics and thromboembolism within a unified mathematical framework. Our approach employs a phase-field model to represent the thrombus system as a continuum undergoing deformation and incorporates information from high-resolution, time-resolved medical imaging to track the thrombus behavior over time in a patient-specific manner. Coagulation cascade pathways are also integrated to mimic thrombus initiation. We test our pipeline with ground-truth data simulations in both idealized, fixed-wall geometries and patient-specific, moving-wall left atrial meshes. We demonstrate its clinical relevance using 4D CT acquisitions from clot- and/or stroke-positive AF patients.

Presenters

  • Clarissa Bargellini

    University of Washington

Authors

  • Clarissa Bargellini

    University of Washington

  • Alejandro Gonzalo

    University of Washington

  • Manuel Guerrero-Hurtado

    University Carlos III De Madrid

  • Pablo Martinez-Legazpi

    Universidad Nacional de Educación a Distancia

  • Javier Bermejo

    Hospital General Universitario Gregorio Marañón

  • Manuel García-Villalba

    TU Wien, Technical University of Vienna

  • Andrew M Kahn

    University of California San Diego

  • Oscar Flores

    University Carlos III De Madrid

  • Juan Carlos del Alamo

    Department of Mechanical Engineering, University of Washington, Seattle, Washington; Center for Cardiovascular Biology, University of Washington, Seattle, Washington, University of Washington